This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Gazyvaro
  • /
  • A Study of Obinutuzumab (RO5072759) Plus Chemother...
Clinical trial

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Read time: 3 mins
Last updated:6th Jul 2011
Identifier: NCT01332968
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest